Provided by Tiger Fintech (Singapore) Pte. Ltd.

Autolus Therapeutics PLC

1.43
+0.08005.93%
Post-market: 1.490.0600+4.20%18:20 EDT
Volume:1.17M
Turnover:1.67M
Market Cap:380.56M
PE:-1.65
High:1.49
Open:1.34
Low:1.33
Close:1.35
Loading ...

European Equities Traded in the US as American Depositary Receipts Modestly Higher in Thursday Trading

MT Newswires Live
·
17 Apr

April 2025's Top Penny Stocks To Watch

Simply Wall St.
·
16 Apr

European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading

MT Newswires Live
·
01 Apr

Autolus Therapeutics Plc : Truist Securities Cuts Target Price to $10 From $11

THOMSON REUTERS
·
01 Apr

Truist Adjusts Price Target on Autolus Therapeutics to $10 From $11, Maintains Buy Rating

MT Newswires Live
·
31 Mar

Wells Fargo Keeps Their Buy Rating on Autolus Therapeutics (AUTL)

TIPRANKS
·
21 Mar

Autolus Therapeutics PLC (AUTL) Q4 2024 Earnings Call Highlights: Financial Growth Amid Rising Costs

GuruFocus.com
·
21 Mar

Q4 2024 Autolus Therapeutics PLC Earnings Call

Thomson Reuters StreetEvents
·
21 Mar

Stock Track | Autolus Therapeutics Surges 5.07% After-Hours on Strong 2024 Results and AUCATZYL Launch Success

Stock Track
·
21 Mar

Stock Track | Autolus Therapeutics Plummets 5.15% on Wider Q4 Loss and Increased Annual Expenses

Stock Track
·
20 Mar

Stock Track | Autolus Therapeutics Plummets 5.15% as Q4 Losses Widen, Missing Estimates

Stock Track
·
20 Mar

Autolus Therapeutics PLC reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
20 Mar

Stock Track | Autolus Therapeutics Plunges 5.12% Pre-market Following Q4 Earnings Miss and Wider Annual Losses

Stock Track
·
20 Mar

Stock Track | Autolus Therapeutics Plunges 5.12% Pre-Market on Wider-Than-Expected Q4 Loss

Stock Track
·
20 Mar

Stock Track | Autolus Therapeutics Soars 7.22% Pre-Market on Strong 2024 Results and Positive Outlook

Stock Track
·
20 Mar

Autolus Therapeutics Launches AUCATZYL® in U.S. Market

TIPRANKS
·
20 Mar

Autolus Therapeutics Q4 2024 GAAP EPS $(0.86) Misses $(0.20) Estimate

Benzinga
·
20 Mar

Press Release: Autolus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Dow Jones
·
20 Mar

Autolus Therapeutics PLC expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
18 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
17 Mar